Kewaunee Scientific Corp Reports 18% Revenue Surge to $240.5M in FY 2025, Driven by Domestic Sales Growth
Kewaunee Scientific Corporation has reported its financial results for the fiscal year ending April 30, 2025. The company, known for its laboratory, healthcare, and technical furniture solutions, achieved sales of $240.5 million, marking a notable increase from the previous fiscal year's sales of $203.8 million. Breaking down the sales, the Domestic Segment saw an impressive rise to $179.4 million, a 30.7% increase from the $137.2 million reported in fiscal year 2024. This growth was significantly influenced by the acquisition of Nu Aire on November 1, 2024. On the other hand, the International Segment experienced a decline in sales, reporting $61.1 million, which is an 8.2% decrease compared to the $66.5 million in the prior fiscal year. The decrease in international sales was attributed to customer site delays in India. Looking ahead, Kewaunee Scientific Corporation acknowledges the challenges in predicting future product demand due to its subcontractor role and dependence on laboratory and healthcare construction projects. Additionally, fluctuations in raw material costs, such as steel, wood, and epoxy resin, are expected to impact earnings. The acquisition of Nu Aire is seen as a strategic move to enhance growth, combining strengths in laboratory and biosafety solutions and aligning with a shared vision for laboratory innovation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000055529-25-000026), on July 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.